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Introduction:
The Neuroblate Fusion system utilizes magnetic
resonance guided laser therapy to ablate tumors and
lesions. The system requires the use of Laser Interstitial
Thermo Therapy (LITT) to activate thermocoagulation
and focus of tissue destruction. This is a minimally
invasive alternative to traditional brain surgery, giving
patients a shorter recovery time and fewer
complications. Neuroblate Fusion may also be an
additional treatment to chemotherapy or radiation
therapy. Neuroblate Fusion is best used for treating
glioblastomas in the brain and occasionally for
reducing the potential for seizures. Under sterile
conditions, a small burr hole is made in the patient’s
skull which allows the neurosurgeon to accurately place
the probe onto the area of interest. Concurrently with
the surgical procedure, real-time magnetic resonance
imaging (MRI) is performed. This helps to assist the
surgeons in precisely locating the glioblastoma and
destroy the carcinogenic tissues with the laser, while
avoiding the surrounding healthy tissues and anatomy.
Neuroblate Fusion is a great treatment option for
patients who are suffering with aggressive tumors such
as glioblastomas. Laser therapy gives patients a new
hope and a better chance of survival. Recurrence of
glioblastomas are common after patients undergo a first
surgery without the use of Neuroblate Fusion.
Destroying the tumor proves to be more successful
after a second surgery is done using laser therapy. In
the future, Neuroblate Fusion may become the gold
standard for treating glioblastomas.

The Role of MRI:
•
•

The Neuroblate Fusion System was approved by the
FDA in 2009. (University Hospitals, 2020, p. 1)
In 2020, Monteris Medical announced FDA
clearance of it’s Neuroblate Fusion-S Software.
(Biospace, 2020, p. 1)

Private company that develops LITT.
• Prior to the MRI of the brain, a computed
tomography (CT) scan of the brain is done to locate
the tumor(s).
• Contrast enhanced MRI remains the primary form of
imaging to assess the size and spread of brain
tumors.
• In contrast enhanced MRI for the evaluation of a
glioblastoma, both inflammation and any abnormal
vasculature will be demonstrated.
• a defining pathologic feature of glioblastomas is
the presence of thick, irregular nodules. (Schmitt &
Stein, 2016, p. 87)

• Real-time MRI helps to assist in the surgical
intervention and treatment of tumors.

Neuroblate Fusion vs. Craniotomy:

https://radiopae
dia.org/images/
15747811?case
_id=39554

https://ghealth121.c
om/treatments/laser
-ablation/

Figure 3. Neuroblate Fusion probe being
used in an OR suite
Figure 1. Axial MR image of a
normal brain without a glioblastoma

Neuroblate Fusion:
•

Neurosurgeons use intraoperative magnetic
resonance imaging (iMRI) to create accurate images
of the brain that guide them in removing brain
tumors, such as glioblastomas.

•

•

Prior to the start of the procedure, the neurosurgeon
plans the surgical approach and chooses which
probe would work best.

•

The patient is then transferred to the operating suite
with their head remaining stabilized.

•

Under MRI guidance, the surgeon accurately places
the probe and delivers the laser energy to ablate the
area of interest. If necessary, a second trajectory can
be made using a single laser probe.

•

Neuroblate Fusion is a minimally invasive
procedure and is tolerated very well by patients.
Most patients are discharged quickly, have a short
recovery time, and only have 1-2 stitches.
Follow-up MRI images of the tumor begin to
show evidence of tumor death immediately after
the procedure.

• Glioblastomas are generally found in the cerebral
hemispheres of the brain.
•

Indications for the use of Neuroblate Fusion include
the size, shape, and location of the tumor.

2018, p. 3)

• The exact cause is unknown.
• Factors that increase the risk of having a
glioblastoma include age (most common), radiation
exposure, and family history.
Age 60 years and older have a higher likelihood
of glioblastoma.
• Treatments include Neuroblate Fusion,
chemotherapy to stop the cancerous cell growth,
target drug therapy to suppress the abnormalities,
tumor excision for removal, and radiation therapy
to destroy the abnormal cells.

• Is the standard surgery for
most brain tumors
• A section of the skull is
removed to access the
tumor
• Risks such as bleeding,
infection, edema, tissue
damage, and hematoma are
more likely to occur
• Average hospital stay is 1
week

•

• A glioblastoma is a rare, life-threatening brain
tumor that originates in the glial cells of the brain
or spinal cord.

• Common symptoms of having a glioblastoma
include headache, memory loss, seizures, speech
and balance difficulties, and confusion. (Newman,

• Minimally invasive
• A small burr hole is made
to insert the probe
• Risks such as bleeding,
infection, edema, tissue
damage, and hematoma are
less likely to occur
(Monteris Medical, 2021, p. 5)
• Average hospital stay is
about 3.5 days (Montemurro,
2020, p. 2)

Figure 2. Axial MR images of a brain with a glioblastoma
pre-operative and 24-hour post-operative (see arrows)

Glioblastoma:

Craniotomy

Neuroblate Fusion is a robotically controlled laser
therapy that also utilizes real-time MRI to ablate
tumors.

Abnormal

https://cco.
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Neuroblate Fusion

https://www.mon
teris.com/health
careprofessionals/ne
uroblate-system/

Figure 4. Robotic probe attached to
patient’s head in the MRI unit

Statistics:
A research study was done to show the outcomes of
survival in patients with glioblastomas who undergo
LITT.
• 17 research articles were found with a total of 203
patients with recurrent glioblastomas who
underwent 219 LITT procedures.
• The morbidity rate was only 6.4%. Zero deaths
reported related to the LITT procedure.
• Average overall survival rate after the initial
diagnosis was 14.7 months. (Montemurro, 2020, p.
2)

•

•

Without treatment for glioblastoma, the average
survival is only a few months, but even with
treatment survival is usually around 1 year.
For patients who have surgery to resect the tumor
along with chemotherapy or radiation therapy, the
overall survival is still only about 14 months.
(Eldridge, 2020, p. 3)

Conclusion:
Overall, Neuroblate Fusion is beneficial for treating
aggressive tumors such as glioblastomas. It is a
minimally invasive alternative to traditional brain
surgery. Research demonstrates that laser therapy is
safe and the overall survival rate for patients is high.
With the Neuroblate system proving to be effective, we
are continuing to provide new hope to patients
suffering with glioblastomas. Real-time MRI laser
therapy allows neurosurgeons to accurately assess the
tumors and plan out the ablation process. In the future,
medical professionals will continue to create better
MRI technology that will improve patient care and
patient’s quality of life. Neuroblate Fusion is relatively
new and is not readily available in every facility.
Researchers are exploring a more widespread use of
laser therapy throughout the world to become the gold
standard of treatment of glioblastomas.
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